StonvexLoading…
StonvexStonvexStonvexCore line items from PTGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $56.37M | $46.02M | $38.58M | $33.87M |
Operating Income | $-3.65M | $-158.13M | $-107.77M | $-61.35M |
Net Income | $3.78M | $-130.15M | $-85.77M | $-46.43M |
EPS (Diluted) | $0.05 | $-2.05 | $-1.35 | $-0.73 |
Total Assets | $697.46M | $668.19M | $701.69M | $718.01M |
Total Liabilities | $41.99M | $53.48M | $56.25M | $49.99M |
Cash & Equivalents | $193.71M | $128.39M | $113.71M | $168.54M |
Free Cash Flow OCF − CapEx | $-49.16M | $56.08M | $93.20M | $95.22M |
Shares Outstanding | 64.23M | 62.58M | 62.45M | 62.11M |